{"id":"gc3107","safety":{"commonSideEffects":[{"rate":null,"effect":"Flu-like symptoms (fever, fatigue, myalgia)"},{"rate":null,"effect":"Hematologic abnormalities (thrombocytopenia, leukopenia)"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Depression / psychiatric effects"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"GC3107 combines human serum albumin with interferon alpha to extend half-life and improve pharmacokinetics compared to native IFN-α. The albumin fusion allows for less frequent dosing while maintaining therapeutic interferon signaling through type I interferon receptors on immune and viral-infected cells.","oneSentence":"GC3107 is a recombinant human albumin-fused interferon alpha (IFN-α) fusion protein that enhances antiviral and immunomodulatory activity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:47.140Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis B"},{"name":"Chronic hepatitis C"}]},"trialDetails":[{"nctId":"NCT03947138","phase":"PHASE3","title":"A Study of GC3107(BCG Vaccine) in Healthy Infants","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2019-08-06","conditions":"BCG Vaccination Reaction, Tuberculosis","enrollment":750},{"nctId":"NCT03363178","phase":"PHASE1","title":"Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults","status":"UNKNOWN","sponsor":"Green Cross Corporation","startDate":"2017-12-14","conditions":"Tuberculosis","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"GC3107","genericName":"GC3107","companyName":"Green Cross Corporation","companyId":"green-cross-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"GC3107 is a recombinant human albumin-fused interferon alpha (IFN-α) fusion protein that enhances antiviral and immunomodulatory activity. Used for Chronic hepatitis B, Chronic hepatitis C.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}